Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$393.52
Buy
$393.63
$-44.06 (-10.08%)
Prices updated at 09 Sep 2026, 00:59 EDT
| Prices minimum 15 mins delay
Prices in USD
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first c ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $410.03 - $391.17 | |
| $447.03 - $269.77 | |
| 2.54 | |
| 236,380.53m | |
| 27.16 | |
| - | |
| 6,831,665 | |
| 20.22 | |
| 2,712,601.76 | |
| 0.01 | |
| 538.80m | |
| US0311621009 | |
| 14.23 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.